Malo, 1. L., Hawkins, R., and Pepys, J. (1977) . Thorax, 32, [254] [255] [256] [257] [258] [259] [260] [261] . Studies in chronic allergic bronchopulmonary aspergiliosis. 1 Clinical and physiological findings. This report outlines the clinical and physiological features in 50 asthmatic patients with chronic allergic bronchopulmonary aspergillosis in whom the diagnosis was made from 2 to 25 years ago (mean duration 10-9 years). From a questionnaire and analysis of the peak expiratory flow rate measurements it was found that they were worse in the winter months, corresponding to the maximal concentrations of Aspergillus fumigatus in the atmosphere. Nineteen patients reported daily sputum production of up to an eggcupful or more, and 24 had noticed sputum 'plugs' in the previous year. Reduction of vital capacity (VC) was found in 20 patients, of forced expiratory volume in one second (FEV1) in 38 patients, and of maximal expiratory flow at 50%VC breathing air (V50air) in 47 patients. Nine patients had significantly reduced gas transfer factor (DLCO). Significant improvement (more than 15%) in FEV, after inhaled bronchodilator was shown by only 17 patients. There were statistically significant correlations between the degree of reduction in the physiological measurements of VC, FEV,, and V50air with the age of the patient at the time of the study and the later in life the diagnosis of aspergillosis was made, whereas the reduction in DLCO was also significantly related to the duration of aspergillosis. Prospective studies are needed for a proper assessment of any protective effect of treatment on the pathophysiological changes due to the disease over many years.
In recent years the acute manifestations of allergic bronchopulmonary aspergillosis have been described (Pepys et al., 1959; Henderson, 1968; Golbert and Patterson, 1970) and its different clinical, physiological (McCarthy and Pepys, 1971a) , radio- logical (McCarthy et al., 1970) , and immunological (McCarthy and Pepys, 1971b) aspects have been studied extensively. Because this disease was described for the first time in this country only 25 years ago (Hinson et al., 1952) , the chronic changes occurring in the affected patients are less well known. A five-year follow-up (Safirstein et al., 1973) (Cherniack and Carton, 1966; Pande et al., 1971; Landau et al., 1974) . It has also been shown in patients with allergic bronchopulmonary aspergillosis that bronchiectasis often develops at the site of the acute shadow (Scadding, 1967; McCarthy et al., 1970) , and the gas transfer factor was reduced in most of the patients who were tested by McCarthy and Pepys (1971a) .
The purposes of the present study are to assess the chronic clinical features and pulmonary function changes in such patients in detail to see whether clinical parameters are related to the degrees of severity and reversibility of the airways obstruction.
Material and methods
Fifty patients with allergic bronchopulmonary aspergillosis are described ( Thomson (1959) . This technique measures directly i a routine alveolar volume by using helium in the test breath with two and may underestimate this volume when the gas ie of these distribution is uneven.
prepared by
The measurements of reversibility were exLred in our pressed in two ways. First, the changes in expira-;ed culture tory measurements after bronchodilator were five weeks compared as percentages of the prebronchodilator
This extract values. Secondly, we compared the actual differntration of ence between the values, expressed in percentages of the predicted, before and after the bronchowere first dilator. four 50 ,ug From the time of diagnosis of aspergillosis, these preparation patients attended regular outpatient clinics when in one sec-their expiratory flow rates (PEFR) were measured. FVC), and In 41 patients, at least five recordings were avail-FV) curves able. For every one of these patients the mean n(02) mix-PEFR in November, December, and January was % respect-compared with the mean at other times of the resistance year. The same information was obtained from a LCO) were control group of 41 adult asthmatics with similar ranges of age, duration, and age at onset of [italograph asthma. All these asthmatics had a negative prick .s produced test to A. fumigatus. The three months of Novemo Ltd) and ber, December, and January were chosen since it lequipment has been shown that Aspergillus spores are more the patient abundant in the atmosphere at this time of the ked to take year (Noble and Clayton, 1963) . ths of the Unpaired t test, chi square, and linear correla--was then tion tests were used for statistical analysis of the tllowed to results.
Results
The age at the time of the study, age at diagnosis of asthma and bronchopulmonary aspergillosis, and duration of asthma and aspergillosis are shown in the Figure. There were 20 men and 30 women whose age range was between 20 and 72 with a mean of 44-5+13-2 years. Twenty-eight patients developed asthma before 10 years and nine after 30 years of age. Most of the patients were longstanding asthmatics with a mean duration of asthma of 304±114 years. Bronchopulmonary aspergillosis was diagnosed after the age of 20 in the majority of patients, and the duration of the disease was from 2 to 25 (mean= 10-9-'-5-2) years. The clinical data obtained from the questionnaire are listed in were admitted to hospital because of acute exacerbations of asthma or aspergillosis. Four patients reported that they had not had asthma or sputum production in the year preceding the visit. The asthma was generally more troublesome during the winter months but was not severe, the majority of patients having less than one attack of wheezing a week. Thirty-nine of the 46 patients judged the control of their asthma to be good. Nineteen patients had up to an eggcupful or more of sputum daily and 24 had noticed 'plugs' in their sputum during the past year.
At the time of their visit the patients were on a variety of treatments listed in Table 3 . Twentyseven were on oral corticosteroids with or without beclomethasone dipropionate, nine on beclomethasone dipropionate only, and four on sodium cromoglycate. As shown in Table 4 , the majority of patients had been on different regimes of treat- In Tables 7 and 8 are the correlations between age at the time of the study, age at diagnosis of bronchopulmonary aspergillosis and asthma, duration of bronchopulmonary aspergillosis and asthma, and the physiological findings. The degree of airways obstruction as measured by FEV1, V50air, and FVC was greater with increasing age and the later in life the diagnosis of aspergillosis was made. These correlations were statistically significant when the values either before or after bronchodilator were considered. The FVC also showed corresponding correlations with the dura-J. L. Malo, R. Hawkins, and J. Pepys At the time of the study eight patients were on oral corticosteroids at a dosage of 7.5 mg or more NS=statistically not significant.
group.bmj.com on June 22, 2017 -Published by http://thorax.bmj.com/ Downloaded from daily in order to relieve their wheezing which was more frequent than in other groups. These clinically more severely affected patients had a significantly (0-01 <P<0-02) reduced DLCO in comparison with the less severely affected patients who were on beclomethasone dipropionate alone or on bronchodilators and/or antibiotics. There were no other statistical differences between any of the differently treated groups in terms of the mean of all function tests.
The patient on oral corticosteroids at a dosage of 7 5 mg or more daily and continuously since the time of diagnosis of aspergillosis had significantly reduced FEV1, FVC (0 001 <P<0 01), and VC (0 01 <P<O0-2) as compared with the group on bronchodilator and/or antibiotics only.
Discussion
The acute manifestations of allergic bronchopulmonary aspergillosis have been well described but the chronic changes are less well known. The patients often develop bronchiectasis at the site of acute shadowing as demonstrated by chest radiograph and bronchogram (Scadding, 1967; McCarthy et al., 1970) and it is thought likely that with time repeated episodes would lead to chronic impairment of Jung function (Turner-Warwick et al., 1975) .
All the patients in our study had asthma. The asthmatic complaints were not on the whole troublesome, the majority having one attack or less a week, and the general control of asthma was considered to be good. The finding that the asthma was preponderantly in the winter months is probably related to the fact that A. fumigatus is more abundant in the air at this time of the year (Noble and Clayton, 1963) . This is supported by the lower mean PEFR demonstrated from November until the end of January in the patients with aspergillosis in contrast to those without allergy to A. fumigatus.
Many of the patients had daily sputum, often copious and of a yellow-green colour. This is more a characteristic of bronchiectasis than of asthma, and indeed McCarthy and Pepys (1971a) reported positive cultures for Staphylococcus aureus, Haemophilus influenzae, and pneumococci with precipitins against them in about two-thirds of the cases. Almost half of our patients reported the intermittent production of 'plugs' during the past year.
Thirty-eight patients had airways obstruction as measured by FEV1 at the time of the study. Fortyseven showed a reduced V,,air. The range of normal values for MEFV curves is still under discussion (Green et al., 1973) (Cherniack and Carton, 1966; Pande et al., 1971; Landau et al., 1974) . Only four of our patients had both a reduced VC and FRC suggesting a restrictive defect. As mentioned above, a pattern of airways obstruction was more commonly found.
Nine patients had a significantly reduced gas transfer factor. This number of patients with abnormal values may be exaggerated. The technique we used (McGrath and Thomson, 1959) , which measures alveolar volume from single-breath helium dilution, may indeed have underestimated the value of DLCO. The apparently low threshold of 75% for normal values was chosen to account for this.
The reduction in gas transfer is considered to be characteristic of the usual form of distal bronchiectasis and proportional to the extent of the disease (Pande et al., 1971) . Although the bronchiectasis of allergic bronchopulmonary aspergillosis is known to affect the proximal bronchi (Scadding, 1967; McCarthy et al., 1970) , a reduction in lung gas transfer factor has been described as an important physiological abnormality of the disease. McCarthy and Pepys (1971a) found that 25 out of 35 patients with bronchopulmonary aspergillosis had a gas transfer of 75% or less of the predicted. This finding was much less frequent in the present series of patients. The technique that they used to measure gas transfer factor-a steady-state method-is different from the singlebreath method in the present study, and this might explain the differences.
An improvement in V5() after He-02 breathing greater than 20% was found in only a small number of our patients. This contrasts with the larger improvement found in normal individuals, in some asthmatics (Despas et al., 1972) , and in subjects with mild airways obstruction (Malo and Leblanc, 1975) . The severity of airways obstruction is considered to be relevant to improvement of flows after He-0, breathing (Benatar et al., 1975) (Scadding, 1967; McCarthy et al., 1970 ) that the radiographic changes of bronchiectasis due to aspergillosis are in the larger airways and that the small airways are generally preserved.
We found that the reduction of FEV1, V50air, and VC was directly related to the age of the patient and the age at which the diagnosis of aspergillosis was made. The reduction bore no correlation with the duration of the aspergillosis. These results might be explained in two ways. The first explanation is that aspergillosis might have been present before it was actually diagnosed and might have produced unsuspected shadow and bronchial damage. In all the patients but one, the diagnosis of aspergillosis was not made before they came to us, and in 41 out of 50 the first chest radiograph showed suggestive chronic changes to be already present (Malo et al., 1977) . It has been found that up to one-third of acute episodes are asymptomatic (Safirstein et al., 1973) and this is a possible explanation for the delay in making the diagnosis. The other explanation may be that the age at the time of diagnosis of aspergillosis has a direct relationship with the extent of damage so that the later in life it starts the more likely it may be to cause severe damage. If this were so, the fact that the majority (6 out of 8) of patients with a single positive prick test to A. fumigatus developed known aspergillosis after the age of 40 may help to identify the patients at risk in this respect.
The reduction in gas transfer factor was nevertheless directly related to the age of the patient, the duration of aspergillosis, and the age at the time of diagnosis of aspergillosis. It bore no correlation with the asthma. This physiological measurement seems, therefore, to be the best index of the severity of the disease.
It was difficult in this retrospective study to assess the results of the treatment. Our patients had been on many different regimes in the past and at the time of the study. As a consequence the treatment groups were small, making statistical analysis less satisfactory. We found, however, that the patients on oral corticosteroids, at a dosage of 7-5 mg or more daily, were those with greater impairment of lung function than the others. These results were also found in a shorter follow-up (Safirstein et al., 1973) . This does not mean that steroids are not helpful in the treatment of the condition, and indeed they have been shown to reduce the duration (McCarthy and Pepys, 1971a) and the number (Safirstein et al., 1973) of acute radiographic shadows. It probably means that the patients who were put on oral corticosteroids at the time of diagnosis had already had damage brought about by unsuspected episodes. Protection from further deterioration would be the main function of corticosteroid treatment in these circumstances. Prospective studies of patients diagnosed and selected for treatment at the very start of the disease may be expected to provide answers to the overall value of corticosteroids or other treatment in the prevention of permanent pathological and physiological impairment.
